Operating Expenses Summary of Starpharma Holdings Limited

Starpharma Holdings Limited's latest annual operating expenses in 2024 was 22.81 Million AUD , down -11.89% from previous year.
Starpharma Holdings Limited's latest quarterly operating expenses in 2024 FY was 22.25 Million AUD , down -14.04% from previous quarter.
Starpharma Holdings Limited reported a annual operating expenses of 25.89 Million AUD in annual operating expenses 2023, up 0.37% from previous year.
Starpharma Holdings Limited reported a annual operating expenses of 25.8 Million AUD in annual operating expenses 2022, down -11.67% from previous year.
Starpharma Holdings Limited reported a quarterly operating expenses of 10.86 Million AUD for 2024 Q4, down 0.0% from previous quarter.
Starpharma Holdings Limited reported a quarterly operating expenses of 22.25 Million AUD for 2024 FY, down -14.04% from previous quarter.

Annual Operating Expenses Chart of Starpharma Holdings Limited (2024 - 1998)

Historical Annual Operating Expenses of Starpharma Holdings Limited (2024 - 1998)

Year	Operating Expenses	Operating Expenses Growth
2024	22.81 Million AUD	-11.89%
2023	25.89 Million AUD	0.37%
2022	25.8 Million AUD	-11.67%
2021	29.2 Million AUD	13.82%
2020	25.66 Million AUD	53.45%
2019	16.72 Million AUD	9.72%
2018	15.24 Million AUD	-19.2%
2017	18.86 Million AUD	-27.06%
2016	25.86 Million AUD	25.3%
2015	20.64 Million AUD	29.98%
2014	15.88 Million AUD	82.46%
2013	8.7 Million AUD	-50.81%
2012	17.69 Million AUD	28.71%
2011	13.74 Million AUD	-1.57%
2010	13.96 Million AUD	-13.47%
2009	16.14 Million AUD	-10.52%
2008	18.04 Million AUD	4.22%
2007	17.3 Million AUD	24.96%
2006	13.85 Million AUD	33.35%
2005	10.38 Million AUD	43.11%
2004	7.25 Million AUD	-17.36%
2003	8.78 Million AUD	-5.07%
2002	9.25 Million AUD	65.71%
2001	5.58 Million AUD	257.56%
2000	-3.54 Million AUD	-51.56%
1999	-2.33 Million AUD	8.0%
1998	-2.54 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	11.38 Million AUD	0.0%
2024 Q4	10.86 Million AUD	0.0%
2024 FY	22.25 Million AUD	-14.04%
2023 Q2	13.13 Million AUD	0.0%
2023 FY	25.89 Million AUD	0.37%
2023 Q4	12.45 Million AUD	0.0%
2022 FY	25.8 Million AUD	-11.67%
2022 Q4	12.55 Million AUD	0.0%
2022 Q2	12.72 Million AUD	0.0%
2021 Q2	14.4 Million AUD	0.0%
2021 Q4	14.81 Million AUD	0.0%
2021 FY	29.2 Million AUD	13.82%
2020 Q4	12.27 Million AUD	0.0%
2020 Q2	13.38 Million AUD	0.0%
2020 FY	25.66 Million AUD	53.45%
2019 FY	16.72 Million AUD	9.72%
2019 Q2	7.92 Million AUD	0.0%
2019 Q4	11.3 Million AUD	0.0%
2018 Q4	7.76 Million AUD	0.0%
2018 FY	15.24 Million AUD	-19.2%
2018 Q2	7.47 Million AUD	0.0%
2017 Q2	8.88 Million AUD	0.0%
2017 FY	18.86 Million AUD	-27.06%
2016 FY	25.86 Million AUD	25.3%
2016 Q2	13.77 Million AUD	0.0%
2015 Q4	11.37 Million AUD	0.0%
2015 Q2	9.26 Million AUD	0.0%
2015 FY	20.64 Million AUD	29.98%
2014 FY	15.88 Million AUD	82.46%
2014 Q4	9.59 Million AUD	0.0%
2014 Q2	6.29 Million AUD	0.0%
2013 Q2	3.12 Million AUD	-24.56%
2013 Q1	4.13 Million AUD	0.0%
2013 Q3	1.91 Million AUD	-38.71%
2013 Q4	4.53 Million AUD	136.84%
2013 FY	8.7 Million AUD	-50.81%
2012 Q1	3.05 Million AUD	0.0%
2012 FY	17.69 Million AUD	28.71%
2012 Q4	4.13 Million AUD	0.0%
2012 Q3	4.13 Million AUD	0.0%
2012 Q2	4.13 Million AUD	35.5%
2011 FY	13.74 Million AUD	-1.57%
2011 Q3	3.05 Million AUD	0.0%
2011 Q1	3.06 Million AUD	0.0%
2011 Q4	3.05 Million AUD	0.0%
2011 Q2	3.05 Million AUD	-0.44%
2010 Q3	3.06 Million AUD	0.0%
2010 FY	13.96 Million AUD	-13.47%
2010 Q2	3.06 Million AUD	-13.07%
2010 Q1	3.52 Million AUD	0.0%
2010 Q4	3.06 Million AUD	0.0%
2009 Q2	3.52 Million AUD	-21.75%
2009 Q3	3.52 Million AUD	0.0%
2009 Q4	3.52 Million AUD	0.0%
2009 Q1	4.51 Million AUD	0.0%
2009 FY	16.14 Million AUD	-10.52%
2008 Q2	4.51 Million AUD	4.22%
2008 Q3	4.51 Million AUD	0.0%
2008 FY	18.04 Million AUD	4.22%
2008 Q4	4.51 Million AUD	0.0%
2008 Q1	4.32 Million AUD	0.0%
2007 FY	17.3 Million AUD	24.96%
2007 Q4	4.32 Million AUD	0.0%
2007 Q1	3.46 Million AUD	0.0%
2007 Q3	4.32 Million AUD	0.0%
2007 Q2	4.32 Million AUD	24.96%
2006 Q1	2.59 Million AUD	0.0%
2006 Q4	3.46 Million AUD	0.0%
2006 Q3	3.46 Million AUD	0.0%
2006 FY	13.85 Million AUD	33.35%
2006 Q2	3.46 Million AUD	33.35%
2005 FY	10.38 Million AUD	43.11%
2005 Q3	2.59 Million AUD	0.0%
2005 Q4	2.59 Million AUD	0.0%
2005 Q2	2.59 Million AUD	43.11%
2005 Q1	1.81 Million AUD	0.0%
2004 Q4	1.81 Million AUD	0.0%
2004 Q1	2.19 Million AUD	0.0%
2004 Q2	1.81 Million AUD	-17.36%
2004 Q3	1.81 Million AUD	0.0%
2004 FY	7.25 Million AUD	-17.36%
2003 Q2	2.19 Million AUD	-3.26%
2003 Q4	2.19 Million AUD	0.0%
2003 Q3	2.19 Million AUD	0.0%
2003 Q1	2.26 Million AUD	0.0%
2003 FY	8.78 Million AUD	-5.07%
2002 Q4	2.26 Million AUD	0.0%
2002 Q3	2.26 Million AUD	0.0%
2002 Q1	-1.38 Million AUD	0.0%
2002 Q2	2.26 Million AUD	264.45%
2002 FY	9.25 Million AUD	65.71%
2001 Q1	-886 Thousand AUD	0.0%
2001 Q2	-1.38 Million AUD	-55.79%
2001 Q4	-1.38 Million AUD	0.0%
2001 Q3	-1.38 Million AUD	0.0%
2001 FY	5.58 Million AUD	257.56%
2000 Q2	-886 Thousand AUD	-51.56%
2000 FY	-3.54 Million AUD	-51.56%
2000 Q4	-886 Thousand AUD	0.0%
2000 Q3	-886 Thousand AUD	0.0%
2000 Q1	-584.58 Thousand AUD	0.0%
1999 FY	-2.33 Million AUD	8.0%
1999 Q1	-635.39 Thousand AUD	0.0%
1999 Q2	-584.58 Thousand AUD	8.0%
1999 Q3	-584.58 Thousand AUD	0.0%
1999 Q4	-584.58 Thousand AUD	0.0%
1998 Q4	-635.39 Thousand AUD	0.0%
1998 Q2	-635.39 Thousand AUD	0.0%
1998 Q3	-635.39 Thousand AUD	0.0%
1998 FY	-2.54 Million AUD	0.0%

Peer Operating Expenses Comparison of Starpharma Holdings Limited

Name	Operating Expenses	Operating Expenses Difference
Anatara Lifesciences Ltd	710.21 Thousand AUD	-3112.539%
BTC Health Limited	-1.03 Million AUD	2296.112%
CSL Limited	7.56 Billion AUD	99.698%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	59.48%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	27.099%
Island Pharmaceuticals Limited	4.12 Million AUD	-453.067%
Orthocell Limited	15.36 Million AUD	-48.449%
Proteomics International Laboratories Limited	892.14 Thousand AUD	-2457.438%
Race Oncology Limited	14.77 Million AUD	-54.47%
AdAlta Limited	6.76 Million AUD	-237.041%
Zelira Therapeutics Limited	5.94 Million AUD	-283.558%
Memphasys Limited	3.67 Million AUD	-520.273%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	-1060.989%
Acrux Limited	8.55 Million AUD	-166.854%
Bio-Gene Technology Limited	2.76 Million AUD	-726.363%
Botanix Pharmaceuticals Limited	601.82 Thousand AUD	-3691.167%
Cynata Therapeutics Limited	11.12 Million AUD	-105.114%
Nyrada Inc.	4.55 Million AUD	-400.882%
PharmAust Limited	6.65 Million AUD	-242.738%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-7524.955%
Arovella Therapeutics Limited	10.78 Million AUD	-111.548%
Alterity Therapeutics Limited	23.4 Million AUD	2.524%
Amplia Therapeutics Limited	8.43 Million AUD	-170.469%
Biome Australia Limited	7.91 Million AUD	-188.4%
Biotron Limited	5.11 Million AUD	-346.438%
Chimeric Therapeutics Limited	19.76 Million AUD	-15.423%
EZZ Life Science Holdings Limited	39.57 Million AUD	42.347%
Immutep Limited	42.87 Million AUD	46.785%
Imugene Limited	135.09 Million AUD	83.111%
Invex Therapeutics Ltd	3.34 Million AUD	-581.913%
Noxopharm Limited	7 Million AUD	-225.934%
Patrys Limited	4.93 Million AUD	-362.488%
Prescient Therapeutics Limited	10.89 Million AUD	-109.344%
PYC Therapeutics Limited	60.91 Million AUD	62.545%
Telix Pharmaceuticals Limited	269.26 Million AUD	91.527%
Dimerix Limited	25.64 Million AUD	11.025%
Hexima Limited	1 Million AUD	-2161.809%
Neuren Pharmaceuticals Limited	32.69 Million AUD	30.22%
Nanollose Limited	12.5 Thousand AUD	-182413.399%
Tissue Repair Ltd	6.66 Million AUD	-242.233%
AnteoTech Limited	12.18 Million AUD	-87.216%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	64.954%
Recce Pharmaceuticals Ltd	21.68 Million AUD	-5.218%
Avecho Biotechnology Limited	4.54 Million AUD	-401.959%
Actinogen Medical Limited	22.77 Million AUD	-0.2%
Immuron Limited	9.13 Million AUD	-149.685%
Argenica Therapeutics Limited	8.26 Million AUD	-175.917%

Global Stocks Search

Starpharma Holdings Limited (SPL.AX)

Operating Expenses Summary of Starpharma Holdings Limited

Annual Operating Expenses Chart of Starpharma Holdings Limited (2024 - 1998)

Historical Annual Operating Expenses of Starpharma Holdings Limited (2024 - 1998)

Peer Operating Expenses Comparison of Starpharma Holdings Limited